New Delhi, Sep 13 (IANS) — The Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) has organised a five-day capacity-building training programme aimed at improving regulation, standardisation, and quality assurance of Ayush drugs, the Ministry of Ayush said on Saturday.
The programme, held in Ghaziabad from September 8 to 12, brought together 27 participants from across the country, including officials from regulatory bodies, research councils, pharmaceutical industries, and academic institutions.
Designed for Drug Enforcement Officers, Quality Control Personnel, and manufacturers, the training featured expert lectures, hands-on laboratory sessions, and industry visits. Technical modules covered pharmacognostic identification, phytochemical analysis, microbiological and pharmacological evaluations, and Good Manufacturing Practices (GMP).
Sessions also focused on shelf-life studies, NABL accreditation, regulatory frameworks, and the standardisation of metal, mineral, and Siddha drugs. Participants gained practical exposure through laboratory training, a visit to the Commission’s herbal garden, and industry interactions at Dr. Willmar Schwabe India (Noida) and Hamdard Laboratories (Ghaziabad).
According to the Ministry, participants praised the blend of expert-led lectures, practical training, and field visits, noting that the programme deepened their understanding of pharmacopoeial standards and regulatory compliance.
The initiative, officials said, reinforces the national commitment to ensuring the safety, efficacy, and quality of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) drugs.
